Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TRLV · against 596 other Healthcare companies listed in US-listed
Ranked #300 of 597 · scores higher than 50% of peers · safety percentile 44
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)33 peers with a safety percentile of 40–49, including TRLV · Click a bar to see the companies
A mix: stronger current ratio, but weaker beta and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TRLV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.75× | 0.23× | 27% | 33% | |
| BetaLower is better · 555 reported | 1.76 | 0.95 | 16% | 33% | |
| Current ratioHigher is better · 600 reported | 5.94× | 3.91× | 64% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.4B USD | 100 | 53 | |
| 1 | 6.4B USD | 100 | 45 | |
| 3 | 176M USD | 100 | 52 | |
| 4 | 1.4B USD | 100 | 44 | |
| 5 | 1.1B USD | 100 | 40 | |
| 296 | 1.6B USD | 46 | 78 | |
| 297 | Unavailable | 45 | 56 | |
| 298 | 96.4B USD | 45 | 18 | |
| 299 | 6.6B USD | 44 | 62 | |
| 300 | 2.1B USD | 44 | 23 | |
| 301 | 165.5B USD | 44 | 64 | |
| 302 | 10.9B USD | 43 | 41 | |
| 303 | 789M USD | 43 | 54 | |
| 304 | 2.6B USD | 43 | 21 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score